CVE-2026-17272

CVE-2026-17272 is a high-severity vulnerability in Ibm I with a CVSS 3.x base score of 8.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-787.

Key facts

Description

IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote attacker to cause a denial of service due to a buffer overflow.

Frequently asked questions

What is CVE-2026-17272?
IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote attacker to cause a denial of service due to a buffer overflow.
How severe is CVE-2026-17272?
CVE-2026-17272 has a CVSS 3.x base score of 8.2, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity low, and availability high.
Is CVE-2026-17272 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (27th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-17272?
CVE-2026-17272 primarily affects Ibm I. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2026-17272?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-17272 published?
CVE-2026-17272 was published on 2026-08-13 and last updated on 2026-08-19.

References

Affected products (4)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-787 (Out-of-bounds Write) vulnerabilities

Browse all CWE-787 (Out-of-bounds Write) vulnerabilities →